Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GBSN

(GBSN) (GBSN) Stock Price, News & Analysis

(GBSN) logo

About (GBSN) Stock (NASDAQ:GBSN)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.10
$0.12
50-Day Range
N/A
52-Week Range
$0.03
$18.00
Volume
104,097 shs
Average Volume
99,205 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.

Remove Ads
Receive GBSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (GBSN) and its competitors with MarketBeat's FREE daily newsletter.

GBSN Stock News Headlines

Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
See More Headlines

GBSN Stock Analysis - Frequently Asked Questions

(GBSN) (NASDAQ:GBSN) announced its quarterly earnings data on Wednesday, March, 22nd. The medical research company reported ($18.25) EPS for the quarter. The medical research company had revenue of $0.85 million for the quarter.

(GBSN) shares reverse split on the morning of Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 15th 2016. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that (GBSN) investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), (BBEPQ) (BBEPQ), BioCryst Pharmaceuticals (BCRX), (UPLMQ) (UPLMQ) and VelocityShares Daily 2x VIX Short-Term ETN (TVIX).

Company Calendar

Last Earnings
3/22/2017
Today
3/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:GBSN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:GBSN) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners